The SLAS Audit Advisory Committee ensures the society’s financial resources are used to advance the society’s exempt purposes by ensuring that SLAS has an annual audit of its financial statements by an independent auditing firm, reviewing the results and recommendations of that audit, and inquiring into any financial matters deemed necessary.
Robyn Rourick, Genentech, Inc.
David Dorsett, Bristol Myers Squibb
Rich Ellson, Labcyte
Peter Grandsard, Amgen
Dan Sipes, GNF